Clinical Trial Update: Anfibatide Phase 1 Clinical Trial in Healthy Volunteers [Phase 1]

View source ↗

Summary

The Phase 1 trial of anfibatide in healthy volunteers has completed, with safety and pharmacokinetic data reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coagulation Disorder
• Coronary Heart Disease

Drugs mentioned

• Anfibatide (anfibatide)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Coronary Heart Disease, Coagulation Disorder | Phase 1 | Status: COMPLETED